DK2209501T3 - Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk cellulose - Google Patents
Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk celluloseInfo
- Publication number
- DK2209501T3 DK2209501T3 DK08806744.2T DK08806744T DK2209501T3 DK 2209501 T3 DK2209501 T3 DK 2209501T3 DK 08806744 T DK08806744 T DK 08806744T DK 2209501 T3 DK2209501 T3 DK 2209501T3
- Authority
- DK
- Denmark
- Prior art keywords
- zibotentan
- composition containing
- microcrystalline cellulose
- containing mannitol
- mannitol
- Prior art date
Links
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 title 1
- 229930195725 Mannitol Natural products 0.000 title 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 title 1
- FJHHZXWJVIEFGJ-UHFFFAOYSA-N N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide Chemical compound COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=2OC=NN=2)C=C1 FJHHZXWJVIEFGJ-UHFFFAOYSA-N 0.000 title 1
- 239000000594 mannitol Substances 0.000 title 1
- 235000010355 mannitol Nutrition 0.000 title 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 title 1
- 239000008108 microcrystalline cellulose Substances 0.000 title 1
- 229940016286 microcrystalline cellulose Drugs 0.000 title 1
- 229950003684 zibotentan Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97973607P | 2007-10-12 | 2007-10-12 | |
| US8911808P | 2008-08-15 | 2008-08-15 | |
| PCT/GB2008/050928 WO2009047565A2 (en) | 2007-10-12 | 2008-10-09 | Composition 064 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2209501T3 true DK2209501T3 (da) | 2012-02-27 |
Family
ID=40534840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08806744.2T DK2209501T3 (da) | 2007-10-12 | 2008-10-09 | Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk cellulose |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US8168221B2 (da) |
| EP (2) | EP2433620A1 (da) |
| JP (1) | JP2011500548A (da) |
| KR (1) | KR20100099113A (da) |
| CN (1) | CN101896210A (da) |
| AR (1) | AR068845A1 (da) |
| AT (1) | ATE536893T1 (da) |
| AU (1) | AU2008309385B2 (da) |
| BR (1) | BRPI0818323A2 (da) |
| CA (1) | CA2701385A1 (da) |
| CL (1) | CL2008003022A1 (da) |
| CO (1) | CO6270344A2 (da) |
| CR (1) | CR11363A (da) |
| CU (1) | CU20100064A7 (da) |
| CY (1) | CY1112433T1 (da) |
| DK (1) | DK2209501T3 (da) |
| DO (1) | DOP2010000105A (da) |
| EA (1) | EA201000545A1 (da) |
| ES (1) | ES2377426T3 (da) |
| HK (1) | HK1143095A1 (da) |
| HR (1) | HRP20120085T1 (da) |
| IL (1) | IL204953A0 (da) |
| MX (1) | MX2010003989A (da) |
| NI (1) | NI201000052A (da) |
| NZ (1) | NZ585310A (da) |
| PE (1) | PE20091032A1 (da) |
| PL (1) | PL2209501T3 (da) |
| PT (1) | PT2209501E (da) |
| SG (1) | SG182138A1 (da) |
| SI (1) | SI2209501T1 (da) |
| SV (1) | SV2010003529A (da) |
| TW (1) | TW200924768A (da) |
| UY (1) | UY31385A1 (da) |
| WO (1) | WO2009047565A2 (da) |
| ZA (1) | ZA201002477B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1644336T1 (sl) | 2003-06-06 | 2011-06-30 | Fibrogen Inc | Heteroarilne spojine, ki vsebujejo duĺ ik in njihova uporaba pri zviĺ anju endogenega eritropoetina |
| CA2701385A1 (en) | 2007-10-12 | 2009-04-16 | Astrazeneca Ab | Composition 064 |
| CN101822796B (zh) * | 2010-03-17 | 2012-01-04 | 山西仟源制药有限公司 | 一种银冰含片及制备方法和应用 |
| US9492395B2 (en) * | 2010-05-11 | 2016-11-15 | Sensient Colors Llc | Film coating composition and methods of making and using the same |
| JO3753B1 (ar) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
| EP2844234B1 (de) * | 2012-04-27 | 2020-01-08 | Merck Patent GmbH | Tabletten mit überzug und deren herstellung |
| US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| PT2872488T (pt) | 2012-07-16 | 2018-11-22 | Fibrogen Inc | Formas cristalinas do ácido [(4-hidroxi-1-metil-7-fenoxi-isoquinolina-3-carbonil)amino]acético inibidor da prolil-hidroxilase |
| WO2014197660A1 (en) | 2013-06-06 | 2014-12-11 | Fibrogen, Inc. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
| BR112022018613A2 (pt) * | 2020-03-31 | 2022-11-08 | Eisai R&D Man Co Ltd | Comprimido, medicamento, métodos para a produção destes e kit |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674794A (en) * | 1970-03-18 | 1972-07-04 | Ciba Geigy Corp | Certain-3-pyridine-sulfonamide derivatives |
| UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
| ES2241133T3 (es) * | 1997-04-28 | 2005-10-16 | Encysive Pharmaceuticals Inc. | Sulfamidas para el tratamiento de los trastornos inducidos por la endotelina. |
| US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| AU5248900A (en) * | 1999-06-18 | 2001-01-09 | Takeda Chemical Industries Ltd. | Quickly disintegrating solid preparations |
| JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
| US20030100595A1 (en) | 2001-11-13 | 2003-05-29 | Aziz Karim | Oral dosage form of a sulfonamide prodrug |
| GB0219660D0 (en) * | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| CA2499149A1 (en) * | 2002-09-20 | 2004-04-01 | Merck & Co., Inc. | Mannitol formulation for integrin receptor antagonist |
| GB0223854D0 (en) | 2002-10-12 | 2002-11-20 | Astrazeneca Ab | Therapeutic treatment |
| GB0320806D0 (en) | 2003-09-05 | 2003-10-08 | Astrazeneca Ab | Therapeutic treatment |
| US7772232B2 (en) | 2004-04-15 | 2010-08-10 | Bristol-Myers Squibb Company | Quinazolinyl compounds as inhibitors of potassium channel function |
| GB0425854D0 (en) | 2004-11-25 | 2004-12-29 | Astrazeneca Ab | Therapeutic treatment |
| CN101032464A (zh) * | 2007-04-01 | 2007-09-12 | 杨喜鸿 | 含有利莫那班和聚乙烯吡咯烷酮的组合物、固体分散体及其制备和药物应用 |
| CA2701385A1 (en) | 2007-10-12 | 2009-04-16 | Astrazeneca Ab | Composition 064 |
-
2008
- 2008-10-09 CA CA2701385A patent/CA2701385A1/en not_active Abandoned
- 2008-10-09 SI SI200830529T patent/SI2209501T1/sl unknown
- 2008-10-09 ES ES08806744T patent/ES2377426T3/es active Active
- 2008-10-09 SG SG2012039327A patent/SG182138A1/en unknown
- 2008-10-09 PL PL08806744T patent/PL2209501T3/pl unknown
- 2008-10-09 PT PT08806744T patent/PT2209501E/pt unknown
- 2008-10-09 MX MX2010003989A patent/MX2010003989A/es active IP Right Grant
- 2008-10-09 NZ NZ585310A patent/NZ585310A/en not_active IP Right Cessation
- 2008-10-09 AT AT08806744T patent/ATE536893T1/de active
- 2008-10-09 EP EP11187017A patent/EP2433620A1/en not_active Withdrawn
- 2008-10-09 WO PCT/GB2008/050928 patent/WO2009047565A2/en active Application Filing
- 2008-10-09 KR KR1020107010484A patent/KR20100099113A/ko not_active Application Discontinuation
- 2008-10-09 DK DK08806744.2T patent/DK2209501T3/da active
- 2008-10-09 BR BRPI0818323A patent/BRPI0818323A2/pt not_active IP Right Cessation
- 2008-10-09 EA EA201000545A patent/EA201000545A1/ru unknown
- 2008-10-09 TW TW097139020A patent/TW200924768A/zh unknown
- 2008-10-09 EP EP08806744A patent/EP2209501B1/en not_active Not-in-force
- 2008-10-09 AU AU2008309385A patent/AU2008309385B2/en not_active Ceased
- 2008-10-09 JP JP2010528486A patent/JP2011500548A/ja active Pending
- 2008-10-09 CN CN2008801210391A patent/CN101896210A/zh active Pending
- 2008-10-10 AR ARP080104448A patent/AR068845A1/es not_active Application Discontinuation
- 2008-10-10 US US12/249,157 patent/US8168221B2/en not_active Expired - Fee Related
- 2008-10-10 CL CL2008003022A patent/CL2008003022A1/es unknown
- 2008-10-10 PE PE2008001750A patent/PE20091032A1/es not_active Application Discontinuation
- 2008-10-10 UY UY31385A patent/UY31385A1/es not_active Application Discontinuation
-
2010
- 2010-04-08 IL IL204953A patent/IL204953A0/en unknown
- 2010-04-08 ZA ZA2010/02477A patent/ZA201002477B/en unknown
- 2010-04-12 CR CR11363A patent/CR11363A/es not_active Application Discontinuation
- 2010-04-12 CU CU20100064A patent/CU20100064A7/es unknown
- 2010-04-12 SV SV2010003529A patent/SV2010003529A/es not_active Application Discontinuation
- 2010-04-12 DO DO2010000105A patent/DOP2010000105A/es unknown
- 2010-04-12 NI NI201000052A patent/NI201000052A/es unknown
- 2010-05-07 CO CO10054830A patent/CO6270344A2/es not_active Application Discontinuation
- 2010-10-13 HK HK10109702.8A patent/HK1143095A1/xx not_active IP Right Cessation
-
2012
- 2012-01-24 HR HR20120085T patent/HRP20120085T1/hr unknown
- 2012-02-09 CY CY20121100136T patent/CY1112433T1/el unknown
- 2012-03-21 US US13/425,474 patent/US20120177705A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2209501T3 (da) | Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk cellulose | |
| BRPI0716325A2 (pt) | Composição antimicrobianas | |
| BRPI0813775A2 (pt) | Composição | |
| FR2899479B1 (fr) | Composition cicatrisante | |
| ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0809573A2 (pt) | composição, e, método | |
| NO20055686D0 (no) | Sammensetning | |
| DE602006001805D1 (de) | Tintenzusammensetzung | |
| DE602006007448D1 (de) | Tintenzusammensetzung | |
| BRPI0810557A2 (pt) | composição | |
| DK2207773T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning deraf. | |
| BRPI0811274A2 (pt) | Composição | |
| DK2125788T3 (da) | Heterocykliske forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse | |
| BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
| BRPI0814167A2 (pt) | Composição, e, método | |
| DK2053921T3 (da) | Ny antifungal sammensætning | |
| BRPI0814748A2 (pt) | Compostos de alditóis substituídos, composições e métodos | |
| BRPI0811002A2 (pt) | Composição biofertilizante | |
| AT8372U3 (de) | Desmopressin umfassende zusammensetzung | |
| BRPI0819202A2 (pt) | Derivado heterocíclico, e, composição farmacêutica | |
| BRPI0820960A2 (pt) | composição | |
| BRPI0816992A2 (pt) | Derivado heterocíclico tricícloco, e, composição farmacêutica | |
| FI20075086L (fi) | Aromikoostumus |